Better immunotherapies | Agenus
WEBAgenus is a biopharmaceutical company that develops immuno-oncology therapeutics for cancer patients. Learn about its lead program botensilimab, a next-generation CTLA-4 …
Pipeline
Pipeline. We are a clinical-stage …Join Us
Agenus approaches this challenge in a different way, beginning with our people. …
Investors
Agenus is an immuno-oncology company focused on the discovery and …
Team
Our Team. Leadership. Board of Directors. Advisory Board. Garo H. Armen, PhD. …
In The News
Forbes. September 20, 2023. New Drug Combo Shows Promising Results …
Press Releases
At Agenus Inc., we promise to treat your data with respect and will not share your …
Events & Presentations
At Agenus Inc., we promise to treat your data with respect and will not share your …
Patients & Care Partners
Agenus is committed to making our therapies available to patients with …
Manufacturing
Internalizing core infrastructure including cGMP manufacturing at commercial …
Clinical
Agenus clinical operations infrastructure includes over 200 personnel and spans …
Our History | Agenus
WEBAgenus is a biopharmaceutical company that develops and manufactures immuno-oncology products, such as checkpoint antibodies, cell therapies, vaccines, and …
Agenus - Wikipedia
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants desugned for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefit…
Wikipedia · Text under CC-BY-SA license- Headquarters: 3 Forbes Road, Lexington, Massachusetts, USA
- Founded: 1994; 29 years ago
- People also ask
Agenus Inc. - ESMO 2023: Agenus’ Botensilimab/Balstilimab …
WEBOct 21, 2023 · Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The …
Agenus | LinkedIn
WEBAgenus is a biotechnology company developing immunological agents for cancer and infectious diseases. Visit www.agenusbio.com for more information, or follow their …
Agenus Inc. - Agenus Completes Enrollment in Randomized Phase …
WEBOct 10, 2023 · Agenus Inc. (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers today announced completion of the planned patient …
- Some results have been removed
Skip to content